Abstract: In the realm of forensic investigation, messenger RNA (mRNA) is a good source for specimen analysis, owing to tissue-specific expression patterns for many transcripts. Thus, differentiation of bodily fluids collected at a crime scene is possible if the proper target mRNA is identifiable and detectable using molecular methods. With the analysis of menstrual blood evidence, for example, the matrix metalloproteinase (MMP) family of genes encodes proteins involved in extracellular matrix breakdown during tissue remodeling, and in particular MMP11 and MMP7 mRNA have proven useful for forensic blood evidence analysis. Nucleic acid sequence based amplification (NASBA) is a highly sensitive RNA transcription-based amplification method used to detect gene expression. As an emerging real-time technology, NASBA holds promise as a tool to rapidly and sensitively amplify mRNA markers associated with the MMP genes to verify the presence of menstrual blood in a forensic sample, and has a number of advantages compared to reverse transcriptase polymerase chain reaction. The purpose of this review is to overview the current state of mRNA analysis in forensic evidence casework and to highlight areas of research, progress, and development in the near-term future that will lead to reduction of case evidence backlog in crime laboratories in developed countries.
Forensic evidence backlog
Forensic backlog occurs when the forensic evidence pertaining to specific criminal cases accumulates due to the inability to properly analyze such evidentiary samples and to produce results pertaining to a particular case. In 2000, the U.S.A. DNA Analysis Backlog Elimination Act was enacted. This legislation effectively dispersed grants to U.S. states to accommodate the collection and analysis of DNA samples from offenders for use in the Federal Bureau of Investigation's (FBI) Combined DNA Index System (CODIS), among other purposes. As of 2003, between 200,000-300,000 convicted offender samples and over 540,000 evidentiary samples (where no suspect has been identified) were still awaiting DNA analysis in the United States (Counterterrorism and Forensic Science Research Unit 2004) .
Since the Backlog Elimination Act was implemented, approximately $50,000,000 USD have been dispersed for DNA analysis of crime scene samples, as well as to increase public laboratories' capabilities to perform DNA analyses (Counterterrorism and Forensic Science Research Unit 2004) . The majority of these funds have been awarded to law enforcement or other government agencies.
The average non-private U.S. forensic laboratory possessed approximately 390 backlogged cases at the beginning 2002; each laboratory then received some 4,900 additional cases, and completed only 4,600 cases within the given year (Peterson & Hickman 2005) . Based upon this information, over 600 cases were backlogged and sample analyses were not performed for this evidence during that particular year per laboratory. With a few isolated exceptions, this trend has remained the same or worsened over the last few years in the U.S.
Nucleic acid as a tool in forensic analyses
Over the past several years, DNA typing has offered much to forensic scientists in terms of sensitivity and power to individualize biological evidence to match the alleged perpetrator (Genge 2002 ). Blood, hair follicles, and other biological evidence, if properly collected and stored, provide valuable material from which forensic investigators extract DNA for analysis. However, even though DNA is an excellent source for verifying the 176 T.I. Counsil & J.L. McKillip perpetrator of a crime, DNA analysis can be controversial. For example, several recent debates have circulated in the literature regarding how many variable regions must be examined to verify that no two individuals share the same DNA homology. Such debate is extremely important considering how easily a jury can be persuaded into believing that a suspect's genetic material was found on criminal evidence based upon the testimony of an "expert" forensic investigator (Moore 2004) .
Even though a DNA fingerprint is unique and can provide a vital link to the true criminal, it is important to remember that the DNA evidence retrieved from the scene of a crime is not necessarily that of the perpetrator. For example, a hair may be found at the crime scene but the individual from whom it originated was not even at the scene when the crime occurred. It is common knowledge that the human body loses large amounts of genetic material in the form of skin, hair, etc., continually, and this genetic material can be dispersed anywhere from the workplace to multiple public areas where a crime could occur (Moore 2004) . Thus, an individual could be placed into custody and could face a trial for a crime that he or she did not commit simply because the DNA evidence was so quickly accepted as the primary source of evidence that links this person to the crime that was committed. For this reason, DNA evidence must be treated equally when compared to other evidence and requires corroboration with other sources such as witnesses or alibis.
Although DNA is typically extracted and analyzed from forensic case evidence, RNA may also be isolated from an evidentiary sample for analysis. Messenger RNA (mRNA) has great promise for forensic analysis because it is expressed in a tissue specific manner and thus can be used to differentiate multiple bodily fluids in a sample collected at a crime scene (Juusola & Ballantyne 2005) . Because each body fluid has a specific transcript profile (transcriptome), a particular fluid residue can be determined based upon its specific mRNA target sequence. For example, the housekeeping gene β-actin is constitutively expressed in human injurious blood, whereas the matrix metalloproteinase 11 (MMP11) gene is present in great abundance only at certain intervals during the human menstrual cycle.
By analyzing the precise abundance or lack of specific mRNAs that are present in an evidentiary sample along with other evidence at the crime scene, investigators can gain insight into the type of crime (e.g. assault, murder) committed and whether DNA typing using short tandem repeat (STR) analysis is necessary (Nussbaumer et al. 2006) . In this study, a realtime reverse transcriptase PCR (RT-PCR) application was developed which allowed for detection of multiple mRNA transcripts expressed in different body fluids such as sweat, saliva, or vaginal secretions. This procedure screened samples containing bodily fluids to quantify the levels of gene expression and to determine whether STR analysis could be performed to produce successful results. mRNA is also an excellent source for forensic investigation due to its relative stability when properly collected and stored. RNA can remain stable and therefore useful for analysis for weeks to months (Nussbaumer et al. 2006) . Another study found that mRNA used for forensic profiling was stable from biological stains up to ten weeks in age and could be successfully detected by RT-PCR, amplified, and visualized using agarose gel electrophoresis (Juusola & Ballantyne 2003) . In a study by Bauer & Patzelt (2002) , RNA sequences allowed for menstrual blood determination, and this RNA target was found to remain in significant, usable quantities after six months of storage. More recently, however, a study by Zubakov et al. (2009) revealed that nine mRNA markers specific to blood identification were amplified from stains ranging between thirteen to sixteen years of age after being held at room temperature and exposed to daylight in a dust-free and non-humid setting. Thus, mRNA stability is dictated by a complex set of variables, including optimal temperature range, hydration state, pH, ultraviolet light, and other factors.
The issue of RNA stability in forensic applications cannot be taken lightly. If a forensic sample is not properly collected and stored, then the mRNA within the evidence can in fact degrade, compromising the evidence perhaps completely. RNA degradation by ribonucleases (RNases) can quickly affect the quantity and quality of RNA that is exposed to an unprotected environment laden with RNases. For this reason, RNase contamination of a forensic sample is the greatest concern investigators must face when working with RNA that is to be analyzed.
Blood evidence
Human blood possesses qualities that can be used to identify either the victim of a crime or the criminal(s). Examination of bloodstains found at the scene of a crime is imperative for determination of blood origin. Forensic serology involves the examination and identification of the effects and properties of bodily fluids such as saliva, sweat, semen, and blood (Gefrides & Welch 2005) . Blood evidence is often found at the scene of violent crimes such as homicide and assault, including sexual assault (Lee & Tirnady 2003) . A majority of cases in forensic serology often specifically involve alleged rape and sexual assaults (Bauer & Patzelt 2002) . Blood discovered at a crime scene may be found in the form of fresh liquid, dried, coagulated, or as small droplets or stains (Lee & Tirnady 2003) . Each form of blood evidence involves a different method of preservation and collection (Gefrides & Welch 2005) , and such protocols will be discussed in greater detail below.
Initially, a residue specimen must be analyzed to determine whether or not it is truly a bloodstain or if it is from some other tissue or bodily fluid. At a crime scene, the chemical luminol may be used to indicate the presence of blood (Fig. 1) . Luminol fluoresces when in contact with blood. In a laboratory setting, investigators obtain a small sample from the stained material Fig. 1 . Hierarchy of presumptive blood tests, ranging from least specific to most specific. Luminol is used to prove that blood of some type is present. The Kastle-Meyer (phenolphthalein) test may also be used to determine whether blood is present on biological specimens. A microcrystalline (Takayama) test is a more specific assay for presence/absence of blood. The precipitin test is used to determine the origin of blood (e.g., human or other animal). The ABO test is used to ascertain human blood type (e.g., A, B, AB, or O), linking blood evidence to other aspects of evidence or suspects.
that has been placed in a saline solution or water (Grodsky et al. 1951) . A small drop of the extracted sample is then placed into a solution containing phenolphthalein ( Fig. 1 ), potassium hydroxide, powdered zinc, and hydrogen peroxide. If the sample within the mixture turns a pink hue, then the sample is indeed blood. This approach, commonly referred to as the Kastle-Meyer test, detects the peroxidase activity of hemoglobin in blood to catalyze phenolphthalein (colorless) oxidation into phenolphthalein (bright pink). If the mixture does not change color then there is no blood present. One should note that the sample is not destroyed by this test and can be stored and reused for further analyses. Another test, known as the Takayama test, is used less commonly to determine whether blood is present within a sample ( Fig. 1 ). This test is performed using hemochromogen crystals (Inman & Rudin 2001) . Blood is present within a sample if pink crystals form after addition of an alkaline pyridine solution and warmed slightly.
The precipitin test is used to determine whether a bloodstain originated from a human or an animal ( Fig. 1 ). Blood from all animal species has different proteins therein; thus, blood from one species will not be accepted by another species based upon the differences in the interacting proteins within the two different blood types (Grodsky et al. 1951) . If specific blood type must be determined, an ABO test can be performed on the sample (Fig. 1) . Using the ABO blood typing system, this test can determine the specific blood type within a sample, thus allowing investigators to narrow down the range of suspects or victims associated with a crime that is under investigation (Tokiwa 1986) .
With regards to rape and sexual assault cases, an important question that must be answered is whether the blood present at the scene of the crime is actually injurious blood or if the bloodstains observed at the crime scene are the result of menstruation bleeding. Such investigation is of utmost importance so as to determine if the victim was assaulted while menstruating and therefore allow investigators to differentiate between venous blood resulting from attack and menstrual blood already present or to determine if the individual is attempting to make fraudulent claims of assault by using the menstrual blood to indicate a potential source of attack when no other indicative evidence has been corroborated.
The identification of menstrual blood has been previously subjected to multiple studies founded upon the microscopic detection of cells that had been shed from endometrial mucosa during menstruation. Furthermore, menstrual blood has been detected and verified based on differences in isozyme patterns, fibrinolytic activity, hormone concentrations, and fibrinfibrinogen degradation products (Bauer & Patzelt 2002) . Isozyme patterns have been used numerous times in several forensic assault cases. For example, lactate dehydrogenase isozyme patterns were used to indicate vaginal injury based on samples extracted from bloodstain spatters found on the pants of a four year old female (Harbison 1992) . The isozyme pattern allowed detectives to determine that the child had been the victim of child abuse.
Fibrinolytic activity is based upon the activity known as fibrinolysis, whereby fibrin (protein that is required for blood clotting) is dissolved and allows for the removal of small blood clots (Christensen 1944 ). An increase in fibrinolytic activity is known to result in the increase of menstrual blood flow due to the removal of the clotting factor. Furthermore, fibrin-fibrinogen degradation products, which are obviously the result of fibrin or fibrinogen breakdown, can be used to detect menstrual blood. Based upon a study regarding drug treatment reduction of fibrin-fibrinogen degradation products (Smith 1998) , one can determine that menstrual blood release is associated with the degradation products of these molecules. Hormone concentrations are also known to increase during the beginning of the menstrual cycle. Thus, one could effectively determine the presence of menstrual blood in a forensic sample based upon the high levels of hormones which are specifically increased during the menstrual cycle. For example, estrogen and lutenizing hormone levels are elevated during menstruation (Kamimori et al. 2000) . Even though these previous detection methods have successfully identified the presence of menstrual blood, problems such as proper evidence storage, handling, and the large quantities of blood necessary for menstrual blood verification were such an issue that new methods for menstrual blood identification needed to be developed.
Based upon the problems associated with the aforementioned detection techniques, a new method for detecting menstrual blood was established via detection of mRNA that is solely expressed in endometrial tissue and not other blood types or epithelial cells (Bauer & Patzelt 2002) . Before explaining the new procedure by which menstrual blood can be detected, it is important to note that the mRNA molecules found in evidentiary samples can expressed specifically in a particular body fluid based upon the cell type and function in which the mRNA is detected. For instance, there are genes specific to menstrual blood that produce mRNA molecules specific to this bodily fluid. One such gene that is expressed in menstrual blood is the MMP11 gene.
The MMP family of genes encodes proteins that are involved in extracellular matrix breakdown associated with a variety of physiological processes, including reproduction, embryonic development, and tissue remodeling. MMPs are zinc-dependent endopeptidases involved in breakdown of extracellular matrix components. These genes are expressed when tissue remodeling and degradation is required; such processes are found to be performed during the menstrual cycle, specifically. MMP genes are expressed in a cycledependent fashion that correlates with menstruation (Bauer & Patzelt 2002) . The MMP genes were examined in great detail during the study of the menstrual cycle using a mouse model system (Kaitu'u et al. 2005) as has been previously mentioned.
The MMP1 gene is considerably upregulated at the time of menstruation and not during other phases of the menstrual cycle. MMP7 has also been shown to be strongly expressed during the menstrual cycle. In fact, MMP7 and MMP3 expression has been discovered during the re24 epithelialization step of endometrium repair after this tissue has been shed (Kaitu'u et al. 2005 ). In the study by Bauer & Patzelt (2002) , only MMP genes and their subsequent protein products have been determined to be frequently expressed in human endometrium, but not in other epithelia such as vaginal mucosa and blood. This study found that the MMP11 gene was specifically expressed in a stronger, more constant manner in menstruation than any other MMP gene family members. Thus, it was originally believed that mRNA from the MMP11 gene could effectively be analyzed using novel techniques for menstrual blood identification.
The matrix metalloproteinase stromelysin-3, or MMP11, gene was initially isolated as a gene associated with breast cancer and has been found to be expressed in a diverse array of human carcinomas and various developmental processes (Fu et al. 2006) . Over 84% of the menstrual blood samples from the Bauer & Patzelt (2002) study were found to possess MMP11 mRNA; conversely, vaginal swabs or traumatic blood samples were analyzed and MMP11 expression was never detected. Samples of menstrual blood obtained from the initial day in which menstruation began revealed a constant expression of MMP11 (Bauer & Patzelt 2002) . The detection of the MMP11 gene in bloodstains retrieved from the scene of a crime will therefore establish the presence of endometrial cells. Based upon this information, the MMP11 gene can be used as a dependable, consistent marker for specific detection of menstrual blood in forensic samples.
Even though MMP11 gene expression is an excellent indicator for menstrual blood identification, there are some drawbacks to using the mRNA produced from this gene for such detection procedures. As previously mentioned, the MMP11 gene was first examined in cancer research studies. Because this gene can be upregulated in tumors, false positive results indicating the presence of menstrual blood when none is present within a sample may be observed (Bauer & Patzelt 2002) . Such results may be produced if a genital tract tumor was the origin of the blood sample; furthermore, origins for bleeding such as the placenta, recent injury, and genital tract infections may produce false positives and can provide erroneous results to forensic investigators attempting to determine whether menstrual blood is present in a forensic evidentiary sample. Based upon this knowledge, however, one should note that MMP11 could be used as a general marker for nontraumatic bleeding from the genital region (Bauer & Patzelt 2002) . Such a discovery could be advantageous for forensic analysis instead of being a limiting factor.
Furthermore, a false positive result could be obtained from a forensic sample that actually contains menstrual blood, but forensic analysis indicates otherwise. If a forensic sample is retrieved from the initial day in which the menstruation cycle is enacted with complete or partial absence of endometrial cells and mRNA from the MMP11 gene are still in low level amounts that cannot be used for forensic analysis (Bauer & Patzelt 2002) , then a sample may be deemed negative for the presence of menstrual blood when the body fluid is indeed present within the sample. Such negative attributes can reduce the effectiveness of utilizing the MMP11 gene as a menstrual blood target and have led researchers to shift focus on alternative and more valuable MMP mRNA markers for use in identifying menstrual blood. Bauer & Patzelt (2008) further published information indicating that a more accurate and precise marker for menstrual blood identification was that of MMP7 as opposed to MMP11. It was found in previous research that primer-probe sets were decidedly difficult to produce for the MMP11 mRNA (Bauer & Patzelt 2008) . Moreover, the researchers determined that MMP7 is more pertinent as a marker for mRNA amplification due to its ability to be amplified through the use of commercially produced testing kits that could be easily acquired by a forensic laboratory for immediate use. MMP11 not only lacks a known testing kit that has documented success with respect to adequate amplification, but its decidedly large amplicon size (455 bp) compared to its MMP7 counterpart (101 bp) makes it a less valuable marker for menstrual blood identification in a forensic laboratory. It should be noted that studies have been reported in which MMP11 was amplified with greater success than previously published after achieving a reduced amplicon size of 200 bp, but such an amplicon is still much larger than mRNA amplified from the MMP7 menstrual blood marker (Ferri et al. 2004 ).
The use of PCR for forensic evidence analysis
Having established the precise marker by which menstrual blood can be identified, one must now understand the new applications by which menstrual blood can be detected in forensic specimens using mRNA. In the study by Juusola & Ballantyne (2003) , mRNA was utilized for identification of body fluid samples. The study used a PCR application known as RT-PCR to verify whether mRNA was present in total RNA extracts retrieved from evidentiary samples containing bodily fluids (Juusola & Ballantyne 2003) . If the precise type and quantity of mRNA from a forensic evidence sample can be determined, then it is possible to identify the specific body fluid or tissue from which the specific mRNA molecule originated. Thus, one could use RT-PCR to screen a biological sample to determine whether there is an adequate amount of genetic material within for forensic analysis to be performed. The study by Bauer & Patzelt (2002) utilized RT-PCR and mRNA to identify menstrual blood stains. This study showed that RT-PCR could successfully identify body fluids from dated forensic cases by using mRNA from the case evidence. By verifying mRNA levels substantial enough to yield RT-PCR results, the likelihood of similarly being able to purify adequate DNA amounts for fingerprint (STR) analyses is also high.
Although using RT-PCR seems to be an excellent idea, this application is not without its drawbacks. Traditional RT-PCR has been determined to be only semi-quantitative due to the application's insensitivity to ethidium bromide (the stain used to observe separated DNA molecules in an electrophoretic gel). However, capillary electrophoresis is now typically used, at least in basic science research laboratories, to assess RT-PCR results. Though this assay is similar to traditional gel electrophoresis, it uses narrow capillary tubes and an electrical current to effectively separate molecules such as DNA or RNA based upon molecular weight (Xu 1993) . Thus, added time is the obvious disadvantage of using RT-PCR in such an approach compared to alternative methods.
Through the advent of real-time detection chemistries in PCR procedures (Wong & Medrano 2005) , unparalleled sensitivity is now possible for forensic DNA analyses. Real-time PCR is capable of detecting extremely small amounts of mRNA, found within a minuscule tissue sample, primary cells (Wong & Medrano 2005) , or in the case of forensics, trace amounts of bodily fluids found at the scene of a crime. Although a complete explanation of real-time PCR detection chemistries is outside the scope of this review, the reader is encouraged to refer to two recent sources that proved a comprehensive perspective on the theory and practice of these approaches (McKillip & Drake 2004; Reddy et al. 2007) .
Aside from RT-PCR (traditional or real-time) aforementioned mRNA applications, there is yet another process by which the mRNA amounts present in a sample can be successfully measured by using a real-time format and existing equipment. This procedure is known as nucleic acid sequence-based amplification, or NASBA. This method is a highly sensitive in vitro RNA transcription based amplification system (Dieman et al. 2002) . The NASBA reaction (Fig. 2) is an isothermic procedure (Compton 1991) The process begins when an oligonucleotide antisense primer (P1) anneals to the RNA target present in the nucleic acid extract obtained from a particular sample. The 3' end of the P1 primer is complementary to the beginning of the target sequence; the 5' P1 end contains the bacteriophage T7 RNA polymerase promoter (Klerks et al. 2001) . After annealing, the reverse transcriptase activity of AMV-RT (avian myeloblastosis virus reverse transcriptase) generates a cDNA complement to the RNA target. The RNA portion of the resulting DNA:RNA hybrid molecule is removed through the action of RNase H. This permits the sense (P2) primer (which is complementary to an upstream portion of the RNA target) to anneal to the cDNA strand. Subsequently, the DNA-dependent DNA polymerase activity of AMV-RT creates a double stranded DNA copy of the original RNA target with a fully functional phage T7 RNA polymerase promoter at one end. The promoter is then identified by the phage T7 RNA polymerase, producing a large amount of antisense single stranded mRNA corresponding to the original RNA target. These antisense RNA transcripts can then function as templates for repeated rounds of NASBA, all performed isothermically, usually at or near 41
The typical level of mRNA amplification is at least a factor of 10 9 (Innovative Biotechnologies Interna-tional 2006). An intermediate product of this reaction is the RNA:DNA heteroduplex formed during the initial amplification cycle (Uyttendaele et al. 1994) . The major NASBA product (amplicon) produced during amplification is mRNA, and this amplicon can be detected in a real-time format as it is being amplified. For instance, fluorescent dyes such as SYBR green-II single-stranded binding dye or molecular beacon probes (Gionata et al. 1998; Gore et al. 2003) can be used to semi-quantify the RNA products produced by NASBA using real-time detection methods. Because NASBA is a closed tube, relatively inexpensive, isothermic procedure that does not require time consuming thermocycling steps otherwise necessary for most PCRrelated applications, this 'emerging technology' offers great promise as an option for sensitive analysis of biological evidentiary specimens.
Crime scene investigation: proper evidence collection and storage
If the NASBA procedure (or any nucleic acid-based method in general) is to be successfully applied to forensic samples, high quality biological specimens must be obtained. If NASBA results are consistently poor or the process is inhibited by environmental contaminants or commonly used evidence storage practices, this procedure will not be validated for forensic evidence analysis. NASBA in forensics is an unexplored area and should be considered for use as a potential methodology from which the sensitivity of PCR forensic specimen analysis could be improved upon. The sensitivity of NASBA over alternative methods such as RT-PCR allows for screening of biological specimens in the presence of a high background of DNA or certain other contaminants, all with the speed offered by isothermic amplification. We now examine how samples may become contaminated and the methods by which police officials and investigators analyze the scene of a crime and retrieve evidence.
Before investigators arrive at a crime scene to begin processing evidence, many sources of contamination are likely already present that either are actively degrading biological specimens, or may carry over during the subsequent laboratory analyses. For example, many household products such as bleach, soaps, etc., may actually inhibit an enzymatic reaction such as PCR or NASBA (Wilson 1997) . Chemicals used for evidence discovery at the scene of a crime, such as phenolphthalein or luminol, may also inhibit subsequent DNA/RNA analysis. Furthermore, environmental contaminants might also be present at the scene of a crime and can lead to PCR inhibition. For example, iron compounds (e.g. rust) have prevented successful results from being obtained through PCR analysis (Levi et al. 2003) . Also, cross contamination of crime scene evidence can occur, whereby DNA, RNA, or other materials from another individual or article found at the crime scene comes in contact with evidentiary samples.
It is possible that the NASBA reaction could be inhibited through the co-purification of the aforementioned contaminants with the RNA template. If unusual levels of inhibitors are suspected to be present, one must perform a purification procedure through which such contamination may be removed from a forensic sample, thereby allowing successful PCR results to be obtained. Even though purification reactions must be performed in order to purify a sample for PCR analysis, such procedures are often time-consuming and laborious. Furthermore, if the source of contamination is not known prior to performing a PCR reaction, more time would have to be allocated to performing secondary reactions to determine the source of contamination and then performing the purification reaction; therefore, a great deal of time would be lost to identifying the source of contamination prior to purification of the forensic evidence, thereby increasing the case backlog already plaguing several forensic laboratories. Because of awareness of this problem, many investigators are trained to examine a crime scene, retrieve evidence, and identify possible sources of contamination. Investigators are fully capable of determining possible sources of contamination and establishing a proper chain of custody to ensure the integrity of any evidentiary samples is not compromised. It is important to also understand that contamination of forensic samples can occur in the laboratory setting, as well. If a forensic laboratory is to validate its results, the laboratory must demonstrate that common procedures decrease contamination that could compromise the reliability of the results obtained from evidence experimentation (Scientific Working Group on DNA Analysis Methods 2004). A laboratory should utilize proper controls and stringently adhere to validated practices to assess contamination and reveal that the procedure being implemented will reduce the presence of contamination. The nature of how the NASBA reaction is assembled and carried out minimizes exogenous contamination risks. NASBA is an isothermal procedure carried out at 41
• C in a closed tube format, and if implemented with a real-time detection chemistry, exhibits unparalleled sensitivity (including the ability to reveal contamination at levels undetectable by analogous methods).
The method utilized for evidence collection can also decrease the chance for contamination. When evidence is collected, it is important to remember that the investigator must follow the laws set forth regarding evidence collection. The NASBA application will be validated only through successful results. Several reactions should be performed using possible contaminants that might be accidentally retrieved along with an evidentiary sample in an attempt to determine if such contamination might inhibit the NASBA procedure. If a list of possible contaminants can be provided by investigators, less time will be allocated to those secondary experiments in which the source of contamination is identified and the mRNA molecules are then purified for successful NASBA results. Furthermore, reactions should be performed using an internal amplification control (IAC) (e.g. glyceraldehyde 3-phosphate dehydrogenase) to de-termine whether or not the NASBA parameters are optimized (Speers 2006; Gracias & McKillip 2007) .
Because NASBA can be performed in a real-time format using a closed-tube reaction vessel, mRNA amplification can be observed with each amplification cycle and with minimal risk of contamination. For these reasons, along with the fact that NASBA does not involve time consuming thermocycling steps, the procedure offers great promise as a screening tool for backlogged biological evidence specimens plaguing crime laboratories worldwide, because the tissue-specific mRNA expression of specific bodily fluids serves as a powerful means of deciphering the nature or circumstances surrounding the physical evidence prior to performing expensive DNA fingerprinting.
Although not yet an approved or widely accepted idea in forensic science, a discipline particularly slow to adopt new and promising approaches, mRNA analysis has much to offer practitioners in criminal justice. With the rapid evolution of molecular tools offering real-time detection sensitivity, more information than ever can potentially be gathered from biological evidence at crime scenes.
